Impinj expects Q4 revenue in range of $91M to $94M, shares down over 7%
[ad_1]
Impinj expects Q4 revenue in range of $91M to $94M, shares down over 7%
[ad_2]
[ad_1] Novartis reports positive results for intrathecal Zolgensma [ad_2]
[ad_1] ICON plc draws bullish views at RBC on attractive valuation [ad_2]
[ad_1] Euro markets trade at a much larger discount the U.S. [ad_2]
[ad_1] Trump asks Supreme Court to pause TikTok ban [ad_2]
[ad_1] Japan's Epson collaborates Kitchen Armor for kitchen solutions [ad_2]
[ad_1] The Arena Group announces NYSE acceptance of plan to regain compliance [ad_2]